Biotricity, Inc. BTCY
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 4.28M | 4.25M | 3.99M | 3.89M | 3.87M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.28M | 4.25M | 3.99M | 3.89M | 3.87M |
| Cost of Revenue | 746.10K | 851.60K | 736.30K | 704.30K | 757.20K |
| Gross Profit | 3.53M | 3.40M | 3.25M | 3.18M | 3.12M |
| SG&A Expenses | 2.70M | 1.86M | 2.19M | 2.30M | 2.14M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.12M | 3.56M | 3.55M | 3.61M | 3.59M |
| Operating Income | 158.10K | 694.60K | 440.90K | 273.80K | 281.90K |
| Income Before Tax | -959.50K | -324.20K | -717.10K | -690.90K | -672.00K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -959.50K | -324.20K | -717.10K | -690.90K | -672.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -959.50K | -324.20K | -717.10K | -690.90K | -672.00K |
| EBIT | 158.10K | 694.60K | 440.90K | 273.80K | 281.90K |
| EBITDA | 159.60K | 696.00K | 442.40K | 275.30K | 283.40K |
| EPS Basic | -0.05 | -0.02 | -0.04 | -0.03 | -0.03 |
| Normalized Basic EPS | -0.03 | -0.01 | -0.02 | -0.02 | -0.02 |
| EPS Diluted | -0.05 | -0.02 | -0.04 | -0.03 | -0.03 |
| Normalized Diluted EPS | -0.03 | -0.01 | -0.02 | -0.02 | -0.02 |
| Average Basic Shares Outstanding | 23.10M | 28.57M | 27.59M | 26.77M | 26.28M |
| Average Diluted Shares Outstanding | 23.10M | 28.57M | 27.59M | 26.77M | 26.28M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -0.63% | -1.85% | -0.84% | -0.89% | -0.88% |